Digital PCR Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

According to Fairfield Market Research, the digital PCR market is expected to grow at a compound annual growth rate (CAGR) of 10% from 2024 to 2031, reaching $182.33 million in 2024 and $354.58 million by the end of 2031. The market's expansion is fueled by strong demand for innovative diagnostic procedures and significant advancements in PCR technology.

Key Market Drivers

1. Technological Advancements in PCR

The digital PCR (dPCR) technology has revolutionized molecular biology by enabling ultrasensitive and repeatable detection and quantification of nucleic acids. Since its initial proposal by Sykes et al. in 1992 and further development by Kalinina et al. in 1997, dPCR has continuously evolved. Innovations such as the Droplet dPCR SARS-CoV-2 Test Kit and the Xpert Xpress SARS-CoV-2 test have significantly contributed to market growth, particularly during the COVID-19 pandemic.

2. Increasing Demand for Diagnostic Tools

The demand for cutting-edge diagnostic tools and therapies is rising due to the increasing incidence of infectious diseases and cancer globally. Digital PCR is widely used in molecular genetic analysis, cancer detection, mutational analysis, and quantitative gene expression studies, making it an indispensable tool in modern diagnostics.

3. Expanding Applications in Various Fields

Digital PCR has broad applications beyond healthcare, including environmental testing, food safety, animal health, and forensic science. The technology's ability to provide accurate results in minimal time with high sensitivity and specificity has driven its adoption in these fields.

Market Dynamics and Insights

Sales Analysis and Market Outlook

The market's growth rate is expected to accelerate in the coming years, with significant contributions from the development of new PCR-based consumables and reagents.

Regional Insights

United States:

The United States accounted for a significant 23.9% share of the global digital PCR market in 2022. This substantial market share is driven by the presence of major pharmaceutical and biotechnology companies, which are at the forefront of innovation and development. High investments in research and development (R&D) further fuel market growth, as these companies continuously strive to develop advanced diagnostic tools and therapies. Additionally, the U.S. benefits from a well-established healthcare infrastructure and strong support from both public and private sectors for genome analysis and related research. The country's robust academic and research institutions also contribute to the widespread adoption of digital PCR technologies, enhancing the market's expansion.

China:

China held a market share of 5.7% in the global digital PCR market in 2022. The surge in demand for PCR tests during the COVID-19 pandemic played a crucial role in boosting the market. China's rapid response to the pandemic included extensive testing and deployment of advanced PCR technologies to manage and control the virus spread. The government's support for R&D in the healthcare sector and the increasing focus on precision medicine and molecular diagnostics have further propelled the digital PCR market. Additionally, the country's efforts to enhance its healthcare infrastructure and the growing number of biotechnology startups are expected to drive continued market growth in the coming years.

Germany:

Germany commanded a dominant 24.1% share of the European digital PCR market in 2022, reflecting its strong position in the region. The country's robust R&D infrastructure and extensive collaboration agreements within the pharmaceutical sector are key growth drivers. Germany is known for its cutting-edge research facilities and significant investments in the life sciences, which foster innovation and the development of advanced diagnostic technologies. The country's emphasis on precision medicine, genetic research, and the integration of digital PCR in clinical and research applications contribute to its leading market position. Additionally, Germany's strategic partnerships with global biotech companies and its support for startup ecosystems create a conducive environment for the growth of the digital PCR market.

Category-wise Insights

Product Segment

Instruments: Instruments held the largest share of the market in 2022, accounting for over 70%. This segment is expected to continue its dominance due to the user-friendly nature and high demand for digital PCR tools in research applications.

End Users

Research Institutes: Research institutes dominated the end-user segment in 2022, with a 70% market share. The increasing demand for developing novel products and understanding disease mechanisms has led to a surge in research activities using PCR technology.

Competitive Analysis

Key players in the digital PCR market are focusing on expanding their product portfolios and obtaining regulatory approvals to strengthen their market presence. Notable developments include:

Bio-Rad Laboratories, Inc.: Received approval from the US FDA for its QXDX AutoDG digital PCR System and the QXDX BCR-ABL %IS Kit.
Thermo Fisher Scientific: Unveiled a new capillary electrophoresis (CE) system for Sanger sequencing and fragment analysis.
Fluidigm Corporation: Entered into a licensing agreement with Baylor Genetics to provide NGS library prep assays for research using the Juno System.

Key Market Players Include

Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Fluidigm Corp.
Formulatrix, Inc.
JN Medsys.
STILLA TECHNOLOGIES
Avance Bioscience
Fluidgm corporation,
jn medsys
Merck KGAA
Precigenome LLC
QIAGEN N.V
Sysmex corporation.

Key Segments of the Digital PCR Industry

By Product:

Instrument
Consumables
Services

By End User:

Pharmaceutical Companies
Research Institutes
Forensic Labs
Agriculture Companies

By Application:

Clinical Diagnostics
Basic Research
Applied Research
Forensic Testing

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Digital PCR Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Price Analysis, 2018 - 2024

3.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2024
3.2. Prominent Factor Affecting Digital PCR Markers Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Digital PCR Market Outlook, 2018 - 2031

4.1. Global Digital PCR Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Instrument
  - 4.1.1.2. Consumables
  - 4.1.1.3. Services
4.2. Global Digital PCR Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Clinical Diagnostics
  - 4.2.1.2. Basic Research
  - 4.2.1.3. Applied Research
  - 4.2.1.4. Forensic Testing
4.3. Global Digital PCR Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Pharmaceutical Companies
  - 4.3.1.2. Research Institutes
  - 4.3.1.3. Forensic Labs
  - 4.3.1.4. Agriculture Companies
4.4. Global Digital PCR Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. North America
  - 4.4.1.2. Europe
  - 4.4.1.3. Asia Pacific
  - 4.4.1.4. Latin America
  - 4.4.1.5. Middle East & Africa

5. North America Digital PCR Market Outlook, 2018 - 2031

5.1. North America Digital PCR Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Instrument
  - 5.1.1.2. Consumables
  - 5.1.1.3. Services
5.2. North America Digital PCR Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Clinical Diagnostics
  - 5.2.1.2. Basic Research
  - 5.2.1.3. Applied Research
  - 5.2.1.4. Forensic Testing
5.3. North America Digital PCR Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Pharmaceutical Companies
  - 5.3.1.2. Research Institutes
  - 5.3.1.3. Forensic Labs
  - 5.3.1.4. Agriculture Companies
5.4. North America Digital PCR Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. U.S. Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.4.1.2. U.S. Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.4.1.3. U.S. Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.4.1.4. Canada Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.4.1.5. Canada Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.4.1.6. Canada Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Digital PCR Market Outlook, 2018 - 2031

6.1. Europe Digital PCR Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Instrument
  - 6.1.1.2. Consumables
  - 6.1.1.3. Services
6.2. Europe Digital PCR Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Clinical Diagnostics
  - 6.2.1.2. Basic Research
  - 6.2.1.3. Applied Research
  - 6.2.1.4. Forensic Testing
6.3. Europe Digital PCR Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Pharmaceutical Companies
  - 6.3.1.2. Research Institutes
  - 6.3.1.3. Forensic Labs
  - 6.3.1.4. Agriculture Companies
6.4. Europe Digital PCR Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Germany Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.2. Germany Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.3. Germany Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.4. U.K. Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.5. U.K. Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.6. U.K. Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.7. France Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.8. France Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.9. France Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.10. Italy Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.11. Italy Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.12. Italy Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.13. Turkey Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.14. Turkey Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.15. Turkey Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.16. Russia Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.17. Russia Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.18. Russia Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.19. Rest of Europe Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.20. Rest of Europe Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.21. Rest of Europe Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Digital PCR Market Outlook, 2018 - 2031

7.1. Asia Pacific Digital PCR Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Instrument
  - 7.1.1.2. Consumables
  - 7.1.1.3. Services
7.2. Asia Pacific Digital PCR Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Clinical Diagnostics
  - 7.2.1.2. Basic Research
  - 7.2.1.3. Applied Research
  - 7.2.1.4. Forensic Testing
7.3. Asia Pacific Digital PCR Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Pharmaceutical Companies
  - 7.3.1.2. Research Institutes
  - 7.3.1.3. Forensic Labs
  - 7.3.1.4. Agriculture Companies
7.4. Asia Pacific Digital PCR Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. China Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.2. China Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.3. China Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.4. Japan Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.5. Japan Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.6. Japan Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.7. South Korea Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.8. South Korea Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.9. South Korea Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.10. India Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.11. India Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.12. India Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.13. Southeast Asia Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.14. Southeast Asia Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.15. Southeast Asia Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.16. Rest of Asia Pacific Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.17. Rest of Asia Pacific Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.18. Rest of Asia Pacific Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Digital PCR Market Outlook, 2018 - 2031

8.1. Latin America Digital PCR Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Instrument
  - 8.1.1.2. Consumables
  - 8.1.1.3. Services
8.2. Latin America Digital PCR Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Clinical Diagnostics
  - 8.2.1.2. Basic Research
  - 8.2.1.3. Applied Research
  - 8.2.1.4. Forensic Testing
8.3. Latin America Digital PCR Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Pharmaceutical Companies
  - 8.3.1.2. Research Institutes
  - 8.3.1.3. Forensic Labs
  - 8.3.1.4. Agriculture Companies
8.4. Latin America Digital PCR Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Brazil Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.2. Brazil Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.3. Brazil Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.4. Mexico Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.5. Mexico Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.6. Mexico Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.7. Argentina Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.8. Argentina Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.9. Argentina Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.10. Rest of Latin America Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.11. Rest of Latin America Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.12. Rest of Latin America Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Digital PCR Market Outlook, 2018 - 2031

9.1. Middle East & Africa Digital PCR Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.1.1. Key Highlights
  - 9.1.1.1. Instrument
  - 9.1.1.2. Consumables
  - 9.1.1.3. Services
9.2. Middle East & Africa Digital PCR Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.2.1. Key Highlights
  - 9.2.1.1. Clinical Diagnostics
  - 9.2.1.2. Basic Research
  - 9.2.1.3. Applied Research
  - 9.2.1.4. Forensic Testing
9.3. Middle East & Africa Digital PCR Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.3.1. Key Highlights
  - 9.3.1.1. Pharmaceutical Companies
  - 9.3.1.2. Research Institutes
  - 9.3.1.3. Forensic Labs
  - 9.3.1.4. Agriculture Companies
9.4. Middle East & Africa Digital PCR Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.4.1. Key Highlights
  - 9.4.1.1. GCC Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.2. GCC Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.3. GCC Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.4. South Africa Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.5. South Africa Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.6. South Africa Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.7. Egypt Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.8. Egypt Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.9. Egypt Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.10. Nigeria Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.11. Nigeria Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.12. Nigeria Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.13. Rest of Middle East & Africa Digital PCR Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.14. Rest of Middle East & Africa Digital PCR Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.15. Rest of Middle East & Africa Digital PCR Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

10.1. Product vs Application Heatmap
10.2. Company Market Share Analysis, 2024
10.3. Competitive Dashboard
10.4. Company Profiles
- 10.4.1. Bio-Rad Laboratories, Inc
  - 10.4.1.1. Company Overview
  - 10.4.1.2. Product Portfolio
  - 10.4.1.3. Financial Overview
  - 10.4.1.4. Business Strategies and Development
- 10.4.2. Thermo Fisher Scientific Inc.
  - 10.4.2.1. Company Overview
  - 10.4.2.2. Product Portfolio
  - 10.4.2.3. Financial Overview
  - 10.4.2.4. Business Strategies and Development
- 10.4.3. Fluidigm Corp.
  - 10.4.3.1. Company Overview
  - 10.4.3.2. Product Portfolio
  - 10.4.3.3. Financial Overview
  - 10.4.3.4. Business Strategies and Development
- 10.4.4. Formulatrix, Inc.
  - 10.4.4.1. Company Overview
  - 10.4.4.2. Product Portfolio
  - 10.4.4.3. Financial Overview
  - 10.4.4.4. Business Strategies and Development
- 10.4.5. JN Medsys.
  - 10.4.5.1. Company Overview
  - 10.4.5.2. Product Portfolio
  - 10.4.5.3. Financial Overview
  - 10.4.5.4. Business Strategies and Development
- 10.4.6. STILLA TECHNOLOGIES
  - 10.4.6.1. Company Overview
  - 10.4.6.2. Product Portfolio
  - 10.4.6.3. Financial Overview
  - 10.4.6.4. Business Strategies and Development
- 10.4.7. Avance Bioscience
  - 10.4.7.1. Company Overview
  - 10.4.7.2. Product Portfolio
  - 10.4.7.3. Financial Overview
  - 10.4.7.4. Business Strategies and Development
- 10.4.8. Fluidgm corporation,
  - 10.4.8.1. Company Overview
  - 10.4.8.2. Product Portfolio
  - 10.4.8.3. Financial Overview
  - 10.4.8.4. Business Strategies and Development
- 10.4.9. QIAGEN N.V
  - 10.4.9.1. Company Overview
  - 10.4.9.2. Product Portfolio
  - 10.4.9.3. Financial Overview
  - 10.4.9.4. Business Strategies and Development
- 10.4.10. Merck KGAA
  - 10.4.10.1. Company Overview
  - 10.4.10.2. Product Portfolio
  - 10.4.10.3. Financial Overview
  - 10.4.10.4. Business Strategies and Development
- 10.4.11. Precigenome LLC
  - 10.4.11.1. Company Overview
  - 10.4.11.2. Product Portfolio
  - 10.4.11.3. Financial Overview
  - 10.4.11.4. Business Strategies and Development

11. Appendix

11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations